Logo
x

Search category

Subscribe Now

Supply Agreement

Merck Signs a Supply Agreement with Werewolf for WTX-124 INDUKINE Program to Treat Solid Tumors

Merck Signs a Supply Agreement with Werewolf for WTX-124 INDUKINE Program to Treat Solid Tumors

  • August 19, 2021
BeiGene Signs a Supply Agreement with PureTech for LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors

BeiGene Signs a Supply Agreement with PureTech for LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors

  • July 8, 2021
Merck Collaborates with OncoSec to Evaluate TAVO (tavokinogene telseplasmid) + Keytruda (pembrolizumab) in P-III KEYNOTE-C87 Trial for Late-Stage Metastatic Melanoma

Merck Collaborates with OncoSec to Evaluate TAVO (tavokinogene telseplasmid) + Keytruda (pembrolizumab) in P-III KEYNOTE-C87 Trial...

  • July 7, 2021
Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19

Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19

  • June 10, 2021
Prestige Biopharma and Pharmapark Sign an Exclusive License and Supply Agreement to Commercialize HD204 (biosimilar- bevacizumab) in Russia

Prestige Biopharma and Pharmapark Sign an Exclusive License and Supply Agreement to Commercialize HD204 (biosimilar- bevacizumab)...

  • April 16, 2021
PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab

PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab

  • March 12, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.